drugset / Trial / NCT02833103

Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction

NCT02833103

RandomizedParallel-groupOpen-labelTreatment

Summary

Sphincter of Oddi dysfunction (SOD) refers to biliary kinetic abnormality of the sphincter of Oddi (SO), often accompanied by pain, hepatic and pancreatic enzyme elevation, common bile duct (CBD) dilation or onset of pancreatitis. Pain caused by SOD affects the quality of life (QoL).The primary objective of this trial is to evaluate the efficacy of relieving abdominal pain of Pinaverium Bromide in medication therapy for patients with post-cholecystectomy SOD.

Timeline

Start
2016-07
Primary completion
2018-02
Completion
2018-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Danshu Capsules Unknown 0.9 g Oral
Subject Pinaverium Small molecule 100 mg Oral

Indications